An animal study demonstrated that tetrathiomolybdate (TTM) provides protective effects in ALS by modulating superoxide dismutase 1 (SOD1) and copper metabolism, restoring abnormally elevated copper levels in the spinal cord (118). The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.